Tokyo, Aug. 31 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058827) titled 'Quantitative Evaluation of Intraocular Structures and Validation of Clinical Utility Using Next-Generation Swept-Source Optical Coherence Tomography' on Aug. 31.
Study Type:
Observational
Primary Sponsor:
Institute - Kyoto University
Condition:
Condition - diabetic retinopathy, age-related macular degeneration, retinal vein occlusion, rhegmatogenous retinal detachment, retinitis pigmentosa, glaucoma
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - This study aims to evaluate the clinical utility of next-generation swept-source optical coherence tomography (OCT) in assisting diagnosis and assessing disease severity of various ocular disorders, including age-related macular degeneration, diabetic retinopathy, and neovascular glaucoma.
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower limit - 18
years-old
=
Gender - Male and Female
Key inclusion criteria - patients having an underlying ocular disorder
Key exclusion criteria - patients with poor fixation
Target Size - 1000
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 08 Month 04 Day
Anticipated trial start date - 2025 Year 08 Month 31 Day
Last follow-up date - 2026 Year 08 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067271
Disclaimer: Curated by HT Syndication.
